Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 3/2012

01.05.2012 | Original Article

Females experience a more severe disease course in batten disease

verfasst von: Jennifer Cialone, Heather Adams, Erika F. Augustine, Frederick J. Marshall, Jennifer M. Kwon, Nicole Newhouse, Amy Vierhile, Erika Levy, Leon S. Dure, Katherine R. Rose, Denia Ramirez-Montealegre, Elisabeth A. de Blieck, Jonathan W. Mink

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Juvenile neuronal ceroid lipofuscinosis (JNCL; CLN3 disease; Batten disease) is an autosomal recessive neurodegenerative disease of childhood. Symptoms typically present at school age with vision loss followed by progressive cognitive decline, motor dysfunction, seizures, and behavior problems. Studies on sex differences in JNCL have yielded mixed results, but parent anecdotes suggest that females experience a more precipitous disease course. Therefore, we sought to determine if sex-based differences exist in JNCL. We used data from the Unified Batten Disease Rating Scale (UBDRS), the Batten Disease Support and Research Association (BDSRA) database, and the PedsQL quality of life (QoL) survey to evaluate sex-based differences in functional independence and time from symptom onset to death. On average, females had JNCL symptom onset one year later and death one year earlier than did males. Despite a later age at onset, females had lower functional capability, earlier loss of independent function, and lower physical QoL. Future research in sex differences in JNCL may help to further understand the biological mechanisms underpinning the disease course and may point to targeted therapies.
Literatur
Zurück zum Zitat Aberg LE, Tiitinen A, Åutti TH, Kivisaari L, Santavouri P (2002) Hyperandrogenism in girls with juvenile neuronal ceroid lipofuscinosis. Eur J Paediatr Neurol 6:199–205PubMedCrossRef Aberg LE, Tiitinen A, Åutti TH, Kivisaari L, Santavouri P (2002) Hyperandrogenism in girls with juvenile neuronal ceroid lipofuscinosis. Eur J Paediatr Neurol 6:199–205PubMedCrossRef
Zurück zum Zitat Adams HR, Kwon J, Marshall FJ, de Blieck EA, Pearce DA, Mink JW (2007) Neuropsychological symptoms of juvenile-onset batten disease: Experiences from 2 studies. J Child Neurol 22:621–627PubMedCrossRef Adams HR, Kwon J, Marshall FJ, de Blieck EA, Pearce DA, Mink JW (2007) Neuropsychological symptoms of juvenile-onset batten disease: Experiences from 2 studies. J Child Neurol 22:621–627PubMedCrossRef
Zurück zum Zitat Adams HR, Beck CA, Levy E et al. (2010) Genotype does not predict severity of behavioural phenotype in juvenile neuronal ceroid lipofuscinosis (batten disease). Dev Med Child Neurol 52:637–643PubMedCrossRef Adams HR, Beck CA, Levy E et al. (2010) Genotype does not predict severity of behavioural phenotype in juvenile neuronal ceroid lipofuscinosis (batten disease). Dev Med Child Neurol 52:637–643PubMedCrossRef
Zurück zum Zitat Bäckman ML, Santavuori PR, Åberg LE, Aronen ET (2005) Psychiatric symptoms of children and adolescents with juvenile neuronal ceroid lipofuscinosis. J Intellect Disabil Res 49:25–32PubMedCrossRef Bäckman ML, Santavuori PR, Åberg LE, Aronen ET (2005) Psychiatric symptoms of children and adolescents with juvenile neuronal ceroid lipofuscinosis. J Intellect Disabil Res 49:25–32PubMedCrossRef
Zurück zum Zitat Boustany R-M (1996). Batten disease or neuronal ceroid lipofuscinosis. Moser HW (ed) Handbook of clinical neurology: Elsevier, Amsterdam, 22(66):671–700 Boustany R-M (1996). Batten disease or neuronal ceroid lipofuscinosis. Moser HW (ed) Handbook of clinical neurology: Elsevier, Amsterdam, 22(66):671700
Zurück zum Zitat Brann DW, Dhandapani K, Wakade C, Mahesh VB, Khan MM (2007) Neurotrophic and neuroprotective actions of estrogen: Basic mechanisms and clinical implications. Steroids 72:381–405PubMedCrossRef Brann DW, Dhandapani K, Wakade C, Mahesh VB, Khan MM (2007) Neurotrophic and neuroprotective actions of estrogen: Basic mechanisms and clinical implications. Steroids 72:381–405PubMedCrossRef
Zurück zum Zitat Chattopadhyay S, Ito M, Cooper JD et al. (2002) An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder batten disease. Hum Mol Genet 11:1421–1431PubMedCrossRef Chattopadhyay S, Ito M, Cooper JD et al. (2002) An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder batten disease. Hum Mol Genet 11:1421–1431PubMedCrossRef
Zurück zum Zitat Gillies GE, McArthur S (2010) Estrogen actions in the brain and the basis for differential action in men and women: A case for sex-specific medicines. Pharmacol Rev 62:155–198PubMedCrossRef Gillies GE, McArthur S (2010) Estrogen actions in the brain and the basis for differential action in men and women: A case for sex-specific medicines. Pharmacol Rev 62:155–198PubMedCrossRef
Zurück zum Zitat Goebel HH, Kohlschütter A (2001) Dementia in the neuronal ceroid-lipofuscinoses. Adv Exp Med Biol 487:211–217PubMedCrossRef Goebel HH, Kohlschütter A (2001) Dementia in the neuronal ceroid-lipofuscinoses. Adv Exp Med Biol 487:211–217PubMedCrossRef
Zurück zum Zitat Grimaldi CM (2006) Sex and systemic lupus erythematosus: The role of the sex hormones estrogen and prolactin on the regulation of autoreactive b cells. Curr Opin Rheumatol 18:456–461PubMedCrossRef Grimaldi CM (2006) Sex and systemic lupus erythematosus: The role of the sex hormones estrogen and prolactin on the regulation of autoreactive b cells. Curr Opin Rheumatol 18:456–461PubMedCrossRef
Zurück zum Zitat Hofman I, Kohlschütter A, Santavuori P et al. (1999). Cln3 juvenile ncl. Goebel HH, Mole SE, Lake BD (eds). The neuronal ceroid lipofuscinoses (batten disease): IOS Press, Amsterdam, pp 55-73 Hofman I, Kohlschütter A, Santavuori P et al. (1999). Cln3 juvenile ncl. Goebel HH, Mole SE, Lake BD (eds). The neuronal ceroid lipofuscinoses (batten disease): IOS Press, Amsterdam, pp 55-73
Zurück zum Zitat Kwon JM, Adams H, Rothberg PG et al. (2011) Quantifying physical decline in juvenile neuronal ceroid lipofuscinosis (batten disease). Neurology 77(20):1801-1807 Kwon JM, Adams H, Rothberg PG et al. (2011) Quantifying physical decline in juvenile neuronal ceroid lipofuscinosis (batten disease). Neurology 77(20):1801-1807
Zurück zum Zitat Lim MJ, Beake J, Bible E et al. (2006) Distinct patterns of serum immunoreactivity as evidence for multiple brain-directed autoantibodies in juvenile neuronal ceroid lipofuscinosis. Neuropathol Appl Neurobiol 32:469–482PubMedCrossRef Lim MJ, Beake J, Bible E et al. (2006) Distinct patterns of serum immunoreactivity as evidence for multiple brain-directed autoantibodies in juvenile neuronal ceroid lipofuscinosis. Neuropathol Appl Neurobiol 32:469–482PubMedCrossRef
Zurück zum Zitat Marshall FJ, de Blieck EA, Mink JW et al. (2005) A clinical rating scale for batten disease: Reliable and relevant for clinical trials. Neurology 65:275–279PubMedCrossRef Marshall FJ, de Blieck EA, Mink JW et al. (2005) A clinical rating scale for batten disease: Reliable and relevant for clinical trials. Neurology 65:275–279PubMedCrossRef
Zurück zum Zitat McCombe PA, Greer JM, Mackay IR (2009) Sexual dimorphism in autoimmune disease. Curr Mol Med 9:1058–1079PubMedCrossRef McCombe PA, Greer JM, Mackay IR (2009) Sexual dimorphism in autoimmune disease. Curr Mol Med 9:1058–1079PubMedCrossRef
Zurück zum Zitat McEwen BS, Alves SE (1999) Estrogen actions in the central nervous system. Endocr Rev 20:279–307PubMedCrossRef McEwen BS, Alves SE (1999) Estrogen actions in the central nervous system. Endocr Rev 20:279–307PubMedCrossRef
Zurück zum Zitat Mondschein ER, Adolph KE, Tamis-LeMonda CS (2000) Gender bias in mothers' expectations about infant crawling. J Exp Child Psychol 77:304–316PubMedCrossRef Mondschein ER, Adolph KE, Tamis-LeMonda CS (2000) Gender bias in mothers' expectations about infant crawling. J Exp Child Psychol 77:304–316PubMedCrossRef
Zurück zum Zitat Morrongiello BA, Dawber T (1999) Parental influences on toddlers' injury-risk behaviors: Are sons and daughters socialized differently? J Appl Dev Psychol 20:227–251CrossRef Morrongiello BA, Dawber T (1999) Parental influences on toddlers' injury-risk behaviors: Are sons and daughters socialized differently? J Appl Dev Psychol 20:227–251CrossRef
Zurück zum Zitat Rothberg PG, Ramirez-Montealegre D, Frazier SD, Pearce DA (2004) Homogeneous polymerase chain reaction nucleobase quenching assay to detect the 1-kbp deletion in cln3 that causes batten disease. J Mol Diagn 6:260–263PubMedCrossRef Rothberg PG, Ramirez-Montealegre D, Frazier SD, Pearce DA (2004) Homogeneous polymerase chain reaction nucleobase quenching assay to detect the 1-kbp deletion in cln3 that causes batten disease. J Mol Diagn 6:260–263PubMedCrossRef
Zurück zum Zitat Rowland T (2005) Aerobic fitness. Children's exercise physiology. Human Kinetics, Champaign, IL Rowland T (2005) Aerobic fitness. Children's exercise physiology. Human Kinetics, Champaign, IL
Zurück zum Zitat Santavuori P, Lauronen L, Kirveskari E, Åberg L, Sainio K, Autti T (2000) Neuronal ceroid lipofuscinoses in childhood. Neurol Sci 21:S35–41PubMedCrossRef Santavuori P, Lauronen L, Kirveskari E, Åberg L, Sainio K, Autti T (2000) Neuronal ceroid lipofuscinoses in childhood. Neurol Sci 21:S35–41PubMedCrossRef
Zurück zum Zitat Seehafer SS, Ramirez-Montealegre D, Wong AM et al. (2011) Immunosuppression alters disease severity in juvenile batten disease mice. J Neuroimmunol 230:169–172PubMedCrossRef Seehafer SS, Ramirez-Montealegre D, Wong AM et al. (2011) Immunosuppression alters disease severity in juvenile batten disease mice. J Neuroimmunol 230:169–172PubMedCrossRef
Zurück zum Zitat Varni JW, Seid M, Kurtin PS (2001) Pedsql 4.0: Reliability and validity of the pediatric quality of life inventory version 4.0 generic core scales in healthy and patient populations. Med Care 39:800–812PubMedCrossRef Varni JW, Seid M, Kurtin PS (2001) Pedsql 4.0: Reliability and validity of the pediatric quality of life inventory version 4.0 generic core scales in healthy and patient populations. Med Care 39:800–812PubMedCrossRef
Metadaten
Titel
Females experience a more severe disease course in batten disease
verfasst von
Jennifer Cialone
Heather Adams
Erika F. Augustine
Frederick J. Marshall
Jennifer M. Kwon
Nicole Newhouse
Amy Vierhile
Erika Levy
Leon S. Dure
Katherine R. Rose
Denia Ramirez-Montealegre
Elisabeth A. de Blieck
Jonathan W. Mink
Publikationsdatum
01.05.2012
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe 3/2012
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-011-9421-6

Weitere Artikel der Ausgabe 3/2012

Journal of Inherited Metabolic Disease 3/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.